Reproterol
Chemical compound
From Wikipedia, the free encyclopedia
Reproterol is a short-acting[1] β2 adrenoreceptor agonist used in the treatment of asthma.[2]
Routes of
administrationInhalation (MDI), IV
administrationInhalation (MDI), IV
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Inhalation (MDI), IV |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.053.579 |
| Chemical and physical data | |
| Formula | C18H23N5O5 |
| Molar mass | 389.412 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
It was patented in 1965 and came into medical use in 1977.[3]
Stereochemistry
Reproterol contains a stereocenter and is chiral. There are thus two enantiomers, the (R)-form and the (S)-form. The commercial preparations contain the drug as a racemate, an equal mixture of the two enantiomers.[4]